Organ Care System (OCS) Heart System

FDA Premarket Approval P180051

Pre-market Approval Supplement Details

Approval for the organ care system (ocs) heart system. This device is indicated for the preservation of donor-after-brain-death (dbd) hearts deemed unsuitable for procurement and transplantation at initial evaluation due to limitations of prolonged cold static cardioplegic preservation (e. G. , > 4 hours of cross-clamp time).

DeviceOrgan Care System (OCS) Heart System
Generic NameOrgan Care System (ocs) Heart System
ApplicantTransMedics, Inc.
Date Received2018-12-26
Decision Date2021-09-03
PMAP180051
SupplementS
Product CodeQIK 
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address TransMedics, Inc. 200 Minuteman Road, Suite 302 andover, MA 01810

Supplemental Filings

Supplement NumberDateSupplement Type
P180051Original Filing
S001 2021-11-08 Panel Track

NIH GUDID Devices

Device IDPMASupp
B00953975 P180051 000
B00913600 P180051 000
B00918043 P180051 000
B00924420 P180051 000
B00925721 P180051 000
B00925741 P180051 000
B00925751 P180051 000
B00926340 P180051 000
B00936363 P180051 000
B00936463 P180051 000
B00943661 P180051 000
B00948225 P180051 000
B00948913 P180051 000
B00949290 P180051 000
B00913390 P180051 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.